AU2002257430A1 - Androgen-mediated neuroprotection and uses thereof - Google Patents

Androgen-mediated neuroprotection and uses thereof

Info

Publication number
AU2002257430A1
AU2002257430A1 AU2002257430A AU2002257430A AU2002257430A1 AU 2002257430 A1 AU2002257430 A1 AU 2002257430A1 AU 2002257430 A AU2002257430 A AU 2002257430A AU 2002257430 A AU2002257430 A AU 2002257430A AU 2002257430 A1 AU2002257430 A1 AU 2002257430A1
Authority
AU
Australia
Prior art keywords
androgen
mediated neuroprotection
neuroprotection
mediated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002257430A
Inventor
Morrie Gelfand
Andrea Leblanc
Mark Trifiro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
McGill University
Original Assignee
McGill University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA002345864A external-priority patent/CA2345864A1/en
Application filed by McGill University filed Critical McGill University
Publication of AU2002257430A1 publication Critical patent/AU2002257430A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
AU2002257430A 2001-05-01 2002-04-30 Androgen-mediated neuroprotection and uses thereof Abandoned AU2002257430A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
CA2,345,864 2001-05-01
CA002345864A CA2345864A1 (en) 2001-05-01 2001-05-01 Androgen-mediated neuroprotection and its use for prevention, treatment and study of neural disease
US29403101P 2001-05-30 2001-05-30
US60/294,031 2001-05-30
US33056701P 2001-10-25 2001-10-25
US60/330,567 2001-10-25
PCT/CA2002/000668 WO2002087552A2 (en) 2001-05-01 2002-04-30 Androgen-mediated neuroprotection and uses thereof

Publications (1)

Publication Number Publication Date
AU2002257430A1 true AU2002257430A1 (en) 2002-11-11

Family

ID=27171527

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002257430A Abandoned AU2002257430A1 (en) 2001-05-01 2002-04-30 Androgen-mediated neuroprotection and uses thereof

Country Status (2)

Country Link
AU (1) AU2002257430A1 (en)
WO (1) WO2002087552A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030083277A1 (en) 2000-02-24 2003-05-01 Hersh Louis B. Use of insulin degrading enzyme (IDE) for the treatment of alzheimer's disease in patients
US9044503B2 (en) 2004-08-27 2015-06-02 University Of Kentucky Research Foundation Amyloid peptide inactivating enzyme to treat alzheimer's disease peripherally
CA2704921C (en) * 2007-11-06 2015-11-24 Ellis L. Kline Compositions and methods for treating parkinson's disease and related disorders
WO2011073419A1 (en) * 2009-12-18 2011-06-23 Institut National De La Sante Et De La Recherche Medicale (Inserm) New steroid inhibitors of pgp for use for inhibiting multidrug resistance
CA3133671C (en) * 2019-06-03 2023-12-19 Aihol Corporation Hyaluronan conjugates and uses thereof
WO2022204827A1 (en) * 2021-03-24 2022-10-06 兰州大学 Application of halcinonide and derivatives thereof for preparing drug treating and/or preventing cerebrovascular disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4791099A (en) * 1984-10-29 1988-12-13 Chaovanee Aroonsakul Method of treatment for central nervous system diseases such as Alzheimer's's disease
JPH06100466A (en) * 1992-02-14 1994-04-12 Tsumura & Co Controlling agent for cerebroneurocytic organ lesion with stress nature
DE4312034A1 (en) * 1993-04-13 1994-10-20 Hesch Rolf Dieter Prof Dr Med Novel androgens and anabolic steroids
US6248358B1 (en) * 1998-08-25 2001-06-19 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets and methods of making and using the same
WO2001072307A1 (en) * 2000-03-29 2001-10-04 The J. David Gladstone Institutes Methods of treating cognitive decline disease conditions with androgens

Also Published As

Publication number Publication date
WO2002087552A3 (en) 2003-10-02
WO2002087552A2 (en) 2002-11-07

Similar Documents

Publication Publication Date Title
AU2002315389A1 (en) Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof
EP1247815A3 (en) Modified oligonucleotides and uses thereof
AU2002367404A1 (en) Redox-switchable materials
AU2002315388A1 (en) Novel phenylamino-pyrimidines and uses thereof
AU2002305523A1 (en) Dioxanes and uses thereof
AU2002359694A1 (en) Compounds and methods
AU2002257430A1 (en) Androgen-mediated neuroprotection and uses thereof
AU2003231827A1 (en) Pseudo-tissues and uses thereof
AU2002338989A1 (en) Substituted C-furan-2-yl-methylamine and C-thiophen-2-yl-methylamine derivatives
AU2002255704A1 (en) Novel anti-adhesive compounds and uses thereof
AU2002251543A1 (en) Novel atisane compound and use thereof
AU2003216442A1 (en) Enkurin and uses thereof
AU2003228397A1 (en) HAUSP-p53 INTERACTION AND USES THEREOF
AU2002322287A1 (en) Novel idolinones and uses thereof
AU2002312558A1 (en) Novel pyridopyrimidones and uses thereof
AU2002306336A1 (en) Novel isoxazolopyridone derivatives and use thereof
AU2002228426A1 (en) Neurotonin and use thereof
AU2002333371A1 (en) Novel 4-aminofuropyrimidines and the use thereof
AU2001100338A4 (en) Sunglove
AU2001100214A4 (en) Dolly-trolley
AU2002335389A1 (en) Blower
AU2002327155A1 (en) Novel rfrp-3 and dna thereof
AU2002238322A1 (en) Abca9 transporter and uses thereof
AU2001244831A1 (en) 3-cyclopentyloxy-4-methoxyphenyl-isoindolinone derivatives and the use thereof
AU2001244832A1 (en) 3-cyclopentyloxy-4-methoxyphenyl-isothiazolinone derivatives and the use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase